TNFAIP6 and metabolic dysfunction-associated steatohepatitis: In a nonalcoholic steatohepatitis (NASH)-like animal model, TSG-6 protected hepatocytes from lipotoxicity by increasing autophagy influx in these cells and attenuated hepatic inflammation and fibrosis [15, 16].